Overall rank by patents
#17,394
Across all tracked assignees
USPTO PatentsView assignee record - 16 granted patents across 11 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H05B (ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL).
The verdict
915 holds 16 US patents across 11 technology areas, rank #17,394 of 50,000 tracked assignees.
915 Labs, Inc. has been granted 16 US utility patents between 2016 and 2025, placing 915 Labs, Inc. at rank #17,394 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.6 claims per patent with primary concentration in H05B (ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL). As a US Corporation, 915 Labs, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, 915 sits between 360° Ballistics, Llc (16 patents, rank #17,390) and Access TO Advanced Health Institute (16 patents, rank #17,398) - the closest US assignees by grant volume. The composite Innovation Score of 35.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 13 grants, compared with 3 in the 2015–2019 window, a +333% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. 915 Labs, Inc.'s 19.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 915 Labs, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
360° BALLISTICS, LLC
16 patents
4Life Patents, LLC
16 patents
6OVER6 VISION LTD.
16 patents
89bio, Inc.
16 patents
AAC Enterprises LLC
16 patents
AADG, INC.
16 patents
ABZAC CANADA INC.
16 patents
ACCESS TO ADVANCED HEALTH INSTITUTE
16 patents
915 Labs, Inc.
16 patents
What this shows 915 holds 16 patents at rank #17,394, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #17,394 in granted patent volume.
Other assignees with the most granted patents in 915's primary technology class.
915's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 48% higher than 52% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 6.3% |
| 2019 | 2 | 12.5% |
| 2020 | 2 | 12.5% |
| 2021 | 6 | 37.5% |
| 2022 | 3 | 18.8% |
| 2024 | 1 | 6.3% |
| 2025 | 1 | 6.3% |
Top 11 of 11 technology areas
Overall rank by patents
#17,394
Across all tracked assignees
35.9 out of 100
How to use this portfolio
915's 16 grants land it in the top 48% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.